The grant year marked the last phase of a down-period in which two major problems were in the process of resolution: insulin whose formulation had changed and required re-formulation and pre-human use testing; and a catheter that required re-design. For this reason, only maintenance procedures were done on the implanted insulin pump patient population. These included pump refills, pump flushes and rinses. When there was battery run-down after ~3 years in a given patient, the pumps were filled with diluting fluid (not insulin) and put on basal rate as patients were converted to conventional insulin delivery.
Showing the most recent 10 out of 1014 publications